Skip to main navigation

Events
Contact

Home
About us
Products
Partnering
Investors
News

Events
Contact

Home
About us
Products
- Overview
- Autoimmunity
  - ARGX-113
- Oncology
- Discovery programs
- Technology
Partnering
Investors
News

Home
Investors
Q3 2019 results

Event Details

Q3 2019 results

24/10/2019

Title

Q3 2019 results

Date / Time

24/10/2019

Stock info

FY 2018 Business Update & Financial Results

Innovative Access Program

Collaboration opportunities under our Innovative Access Program

Print
RSS
Email Alerts

Contact

argenx SE
Breda, The Netherlands
T +31 763 030 488

info@argenx.com

argenx BVBA
Zwijnaarde, Belgium
T +32 9 310 34 00

Downloads

ARGX-113 poster MG Conference NY Annual report 2016 Corporate presentation

Follow us

2024 © argenx

| Disclaimer | Cookie policy | Sitemap

Home
About us
Products
Partnering
Investors
News

Created by Cantilis